Advertisement

Cancer-Associated Retinopathy

  • Maggie M. Wei
  • Karen R. Armbrust
  • Brett G. Jeffrey
  • H. Nida Sen
Living reference work entry

Abstract

Cancer-associated retinopathy (CAR) is a subgroup of autoimmune retinopathy caused by paraneoplastic anti-retinal antibodies. It is characterized by bilateral, rapidly progressive, painless vision loss, often out of proportion to the clinical exam. Visual field testing typically shows scotomas and/or constriction. Electroretinography (ERG) often shows decreased amplitudes or delayed peak-times but may be within normal range or near-normal early in the disease.

Keywords

Optical Coherence Tomography Retinal Pigment Epithelium Visual Field Loss Fundus Autofluorescence Visual Field Constriction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Reading

  1. Abazari A, Allam SS, Adamus G, Ghazi NG. Optical coherence tomography findings in autoimmune retinopathy. Am J Ophthalmol. 2012;153:750–6, 756.e1.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Adamus G. Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy. Autoimmun Rev. 2009;8:410–4.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Braithwaite T, Holder GE, Lee RWJ, Plant GT, Tufail A. Diagnostic features of the autoimmune retinopathies. Autoimmun Rev. 2014;13:534–8.CrossRefPubMedGoogle Scholar
  4. Chan JW. Paraneoplastic retinopathies and optic neuropathies. Surv Ophthalmol. 2003;48:12–38.CrossRefPubMedGoogle Scholar
  5. Comlekoglu DU, Thompson IA, Sen HN. Autoimmune retinopathy. Curr Opin Ophthalmol. 2013;24:598–605.CrossRefPubMedGoogle Scholar
  6. Grange L, Dalal M, Nussenblatt RB, Sen HN. Autoimmune retinopathy. Am J Ophthalmol. 2014;157:266–72.e1.CrossRefPubMedGoogle Scholar
  7. Lima LH, et al. Hyperautofluorescent ring in autoimmune retinopathy. Retina. 2012;32:1385–94.CrossRefPubMedPubMedCentralGoogle Scholar
  8. Pepple KL, Cusick M, Jaffe GJ, Mruthyunjaya P. SD-OCT and autofluorescence characteristics of autoimmune retinopathy. Br J Ophthalmol. 2013;97:139–44.CrossRefPubMedGoogle Scholar
  9. Shildkrot Y, Sobrin L, Gragoudas ES. Cancer-associated retinopathy: update on pathogenesis and therapy. Semin Ophthalmol. 2011;26:321–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer India (outside the USA) 2016

Authors and Affiliations

  • Maggie M. Wei
    • 1
  • Karen R. Armbrust
    • 1
  • Brett G. Jeffrey
    • 2
  • H. Nida Sen
    • 1
  1. 1.Laboratory of ImmunologyNational Eye Institute, National Institutes of HealthBethesdaUSA
  2. 2.Ophthalmic Genetics and Visual Function BranchNational Eye Institute, National Institutes of HealthBethesdaUSA

Personalised recommendations